Second update - Early Access to Medicines Scheme for Remdesivir in the treatment of COVID-19. Implementation of the scheme and management of supply

Given current positive medicine supply levels further (restrictive) access criteria beyond those described in the EAMS scientific opinion have now been removed. The access criteria may be further updated, for example as further evidence emerges, and / or if medicine supply varies


Medicines and Healthcare products Regulatory Agency